AMF Tjanstepension AB Has $32.15 Million Position in HCA Healthcare, Inc. $HCA

AMF Tjanstepension AB cut its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 39.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 75,443 shares of the company’s stock after selling 50,143 shares during the period. AMF Tjanstepension AB’s holdings in HCA Healthcare were worth $32,154,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the company. Brighton Jones LLC bought a new stake in shares of HCA Healthcare during the 4th quarter valued at $1,021,000. NewEdge Advisors LLC grew its stake in HCA Healthcare by 11.9% during the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after buying an additional 409 shares in the last quarter. Sivia Capital Partners LLC raised its position in shares of HCA Healthcare by 5.5% in the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after buying an additional 33 shares in the last quarter. Farther Finance Advisors LLC increased its stake in HCA Healthcare by 22.6% in the second quarter. Farther Finance Advisors LLC now owns 1,399 shares of the company’s stock valued at $536,000 after acquiring an additional 258 shares during the last quarter. Finally, Fifth Third Bancorp boosted its holdings in shares of HCA Healthcare by 2.0% in the 2nd quarter. Fifth Third Bancorp now owns 9,350 shares of the company’s stock valued at $3,582,000 after purchasing an additional 186 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the transaction, the executive vice president directly owned 3,487 shares in the company, valued at approximately $1,652,105.73. This represents a 52.74% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.30% of the company’s stock.

Analyst Ratings Changes

Several research firms recently weighed in on HCA. KeyCorp reaffirmed an “overweight” rating and issued a $500.00 price objective on shares of HCA Healthcare in a research note on Thursday. TD Cowen reaffirmed a “buy” rating on shares of HCA Healthcare in a report on Monday, October 27th. Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a research note on Monday, October 27th. UBS Group increased their price target on HCA Healthcare from $495.00 to $525.00 and gave the company a “buy” rating in a research note on Monday, October 27th. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of HCA Healthcare in a research report on Monday, December 29th. Fourteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $488.75.

HCA Healthcare Stock Up 0.9%

HCA opened at $470.52 on Friday. The stock has a market cap of $107.37 billion, a PE ratio of 18.19, a price-to-earnings-growth ratio of 1.30 and a beta of 1.36. HCA Healthcare, Inc. has a twelve month low of $295.00 and a twelve month high of $520.00. The company has a fifty day moving average of $480.37 and a 200-day moving average of $433.92.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm had revenue of $19.16 billion during the quarter, compared to the consensus estimate of $18.55 billion. During the same period last year, the business posted $4.90 EPS. The business’s revenue was up 9.6% compared to the same quarter last year. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.